Company news
Standard Biotools Inc. (NASDAQ:LAB) news
Standard Biotools Inc. news releases on 6ix. Latest, Oct 5, 2026: Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
Press releases & updates
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
October 5, 2026
Standard BioTools Provides Update on Sale of Mass Cytometry Business
September 30, 2026
Standard BioTools: Q2 Earnings Snapshot
August 5, 2026
Standard BioTools Reports Second Quarter 2026 Financial Results
August 5, 2026
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
July 28, 2026
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
July 20, 2026
Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 7, 2026
Standard BioTools Reports First Quarter 2026 Financial Results
May 5, 2026
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
April 21, 2026
Labrador Gold Announces Closing of Change of Business and Acquisition of Units of Northern Shield
March 9, 2026
CORRECTION – Labrador Gold Announces Voting Results of the 2026 Annual General and Special Meeting of Shareholders
February 25, 2026
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
Standard BioTools Completes Sale of SomaLogic to Illumina
January 30, 2026
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
January 8, 2026
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
November 19, 2025
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
November 10, 2025
Standard BioTools Reports Third Quarter 2025 Financial Results
November 4, 2025
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
October 21, 2025
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
September 3, 2025
Standard BioTools Reports Second Quarter 2025 Financial Results
August 11, 2025
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
August 6, 2025
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
July 21, 2025
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
June 25, 2025
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
June 23, 2025
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
May 30, 2025
Standard BioTools : LAB Q1 2025 Earnings Financial Slides FINAL 3
May 7, 2025
Standard BioTools Reports First Quarter 2025 Financial Results
May 6, 2025
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
April 24, 2025
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
April 22, 2025
Standard BioTools to Participate in Upcoming Investor Conferences
February 27, 2025
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025
February 11, 2025
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
January 12, 2025
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
Standard BioTools Appoints Alex Kim as Chief Financial Officer
November 6, 2024
Standard BioTools Reports Third Quarter 2024 Financial Results
October 29, 2024
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024
October 15, 2024
Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform
September 23, 2024
Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)
September 17, 2024
Standard BioTools Reports Second Quarter 2024 Financial Results
July 30, 2024
Standard BioTools Announces Senior Leadership Changes
July 30, 2024
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024
July 16, 2024
Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers
May 27, 2024
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2024
Standard BioTools Reports First Quarter 2024 Financial Results
May 7, 2024
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
April 24, 2024
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
April 7, 2024